Atjaunināt sīkdatņu piekrišanu

KRAS: Methods and Protocols 2024 ed. [Hardback]

Edited by , Edited by
  • Formāts: Hardback, 365 pages, height x width: 254x178 mm, 69 Illustrations, color; 14 Illustrations, black and white; XI, 365 p. 83 illus., 69 illus. in color., 1 Hardback
  • Sērija : Methods in Molecular Biology 2797
  • Izdošanas datums: 04-Apr-2024
  • Izdevniecība: Springer-Verlag New York Inc.
  • ISBN-10: 1071638211
  • ISBN-13: 9781071638217
Citas grāmatas par šo tēmu:
  • Hardback
  • Cena: 198,63 €*
  • * ši ir gala cena, t.i., netiek piemērotas nekādas papildus atlaides
  • Standarta cena: 233,69 €
  • Ietaupiet 15%
  • Grāmatu piegādes laiks ir 3-4 nedēļas, ja grāmata ir uz vietas izdevniecības noliktavā. Ja izdevējam nepieciešams publicēt jaunu tirāžu, grāmatas piegāde var aizkavēties.
  • Daudzums:
  • Ielikt grozā
  • Piegādes laiks - 4-6 nedēļas
  • Pievienot vēlmju sarakstam
  • Formāts: Hardback, 365 pages, height x width: 254x178 mm, 69 Illustrations, color; 14 Illustrations, black and white; XI, 365 p. 83 illus., 69 illus. in color., 1 Hardback
  • Sērija : Methods in Molecular Biology 2797
  • Izdošanas datums: 04-Apr-2024
  • Izdevniecība: Springer-Verlag New York Inc.
  • ISBN-10: 1071638211
  • ISBN-13: 9781071638217
Citas grāmatas par šo tēmu:
This volume details protocols ranging from high yield production metabolically labeled KRAS for NMR studies to approaches that quantify engagement of novel molecules that bind KRAS in live cells. Chapters focus on protein production and characterization, biochemical assays, cell-based assays, KRAS-membrane interactions, targeting KRAS, and cell models. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and key tips on troubleshooting and avoiding known pitfalls.





 





Authoritative and cutting-edge, KRAS: Methods and Protocols aims to provide methods that will be instrumental in the development of future clinically approved KRAS therapeutics.
KRAS as a therapeutic target.- The abundance of KRAS and RAS gene
mutations in cancer.- Production of isotopically labeled KRAS4b.- Nucleotide
Exchange on RAS Proteins using Hydrolysable and Non-Hydrolysable
Nucleotides.- Crystallographic studies of KRAS in Complex with Small
Molecules and RAS-binding Proteins.- Considerations around Structure-Based
Drug Discovery for KRAS using DOCK.- Measurement of KRAS GTPase
activity.- Affinity Measurement of Non-covalent Interactions of the covalent
KRAS G12C GDP inhibitor MRTX849 to RAS Isoforms using Surface Plasmon
Resonance.- 1D and 2D NMR for KRAS:ligand binding.- Luminescence based
techniques for KRAS thermal stability monitoring.- MALDI-TOF mass
spectrometry-based assay for measuring covalent target engagement of KRAS
G12C inhibitors.- KRAS4b:RAF-1 Homogenous Time-Resolved Fluorescence
Resonance Energy Transfer Assay for Drug Discovery.- Biophysical
characterization of RAS-SOS Complexes by Native Mass Spectrometry.- Profiling
complex RAS-effector interactions using NMR spectroscopy.- Probing RAS
Function Using Monobody and NanoBiT Technologies.- Analysis of the guanine
nucleotide-bound state of KRAS by ion-pair reversed-phase high-performance
liquid chromatography.- Real-time monitoring of RAS activity using in vitro
and in-cell NMR spectroscopy.- Studying RAS Interactions in live cells with
BRET.- FLIM-FRET Protein-Protein Interaction Assay.- High-throughput
cell-based screening of small molecule KRAS signaling inhibitors using a
homogeneous time resolved fluorescence (HTRF) assay.- A method to
conditionally measure target engagement at intracellular RAS and RAF
complexes.- FLAG-KRAS4B as a model system for KRAS4B proteoform and PTM
evaluation by mass spectrometry .- Creation of an isogenic H/N/KRAS-less
mouse embryonic fibroblast cell line panel derived from a size sorted diploid
clone.- Quality Control ofan Isogenic H/N/KRAS-less Mouse Embryonic
Fibroblast Cell Line Panel.- A Facile Method to Append a Bio-ID Tag to
Endogenous Mutant Kras Alleles.